Antimicrobial resistance in Clostridium difficile ribotype 017

被引:23
作者
Imwattana, Korakrit [1 ,2 ]
Knight, Daniel R. [3 ]
Kullin, Brian [4 ]
Collins, Deirdre A. [5 ]
Putsathit, Papanin [5 ]
Kiratisin, Pattarachai [2 ]
Riley, Thomas, V [1 ,3 ,5 ,6 ]
机构
[1] Univ Western Australia, Sch Biomed Sci, Crawley, Australia
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand
[3] Murdoch Univ, Med Mol & Forens Sci, Murdoch, WA, Australia
[4] Univ Cape Town, Dept Mol & Cell Biol, Cape Town, South Africa
[5] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, Australia
[6] Queen Elizabeth II Med Ctr, PathWest Lab Med, Nedlands, WA 6009, Australia
基金
英国医学研究理事会;
关键词
Antimicrobial resistance; Clostridium difficile; outbreak; prevention; ribotype; 017; ANTIBIOTIC-ASSOCIATED DIARRHEA; CLINICAL-PRACTICE GUIDELINES; PCR-RIBOTYPE; RISK-FACTORS; IN-VITRO; FLUOROQUINOLONE RESISTANCE; TETRACYCLINE RESISTANCE; GENETIC ELEMENTS; DISEASES SOCIETY; DOMINANT STRAIN;
D O I
10.1080/14787210.2020.1701436
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Antimicrobial resistance (AMR) played an important role in the initial outbreaks of Clostridium difficile infection (CDI) in the 1970s. C. difficile ribotype (RT) 017 has emerged as the major strain of C. difficile in Asia, where antimicrobial use is poorly regulated. This strain has also caused CDI outbreaks around the world for almost 30 years. Many of these outbreaks were associated with clindamycin and fluoroquinolone resistance. AMR and selective pressure is likely to be responsible for the success of this RT and may drive future outbreaks. Areas covered: This narrative review summarizes the prevalence and mechanisms of AMR in C. difficile RT 017 and transmission of these AMR mechanisms. To address these topics, reports of outbreaks due to C. difficile RT 017, epidemiologic studies with antimicrobial susceptibility results, studies on resistance mechanisms found in C. difficile and related publications available through Pubmed until September 2019 were collated and the findings discussed. Expert opinion: Primary prevention is the key to control CDI. This should be achieved by developing antimicrobial stewardship in medical, veterinary and agricultural practices. AMR is the key factor that drives CDI outbreaks, and methods for the early detection of AMR can facilitate the control of outbreaks.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 102 条
[1]   Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA [J].
Ackermann, G ;
Tang, YJ ;
Kueper, R ;
Heisig, P ;
Rodloff, AC ;
Silva, J ;
Cohen, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2348-2353
[2]   In vitro activity of linezolid against Clostridium difficile [J].
Ackermann, G ;
Adler, D ;
Rodloff, AC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) :743-744
[3]   Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile [J].
Ackermann, G ;
Tang-Feldman, YJ ;
Schaumann, R ;
Henderson, JP ;
Rodloff, AC ;
Silva, J ;
Cohen, SH .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (06) :526-530
[4]   The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? [J].
Alcala, L. ;
Martin, A. ;
Marin, M. ;
Sanchez-Somolinos, M. ;
Catalan, P. ;
Pelaez, T. ;
Bouza, E. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (07) :E204-E213
[5]   Relatedness of Human and Animal Clostridium difficile PCR Ribotype 078 Isolates Determined on the Basis of Multilocus Variable-Number Tandem-Repeat Analysis and Tetracycline Resistance [J].
Bakker, D. ;
Corver, J. ;
Harmanus, C. ;
Goorhuis, A. ;
Keessen, E. C. ;
Fawley, W. N. ;
Wilcox, M. H. ;
Kuijper, E. J. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (10) :3744-3749
[6]  
Balfour JAB, 1999, DRUGS, V57, P363
[7]   Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type [J].
Barbanti, Fabrizio ;
Spigaglia, Patrizia .
ANAEROBE, 2016, 42 :123-129
[8]   Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates [J].
Barbut, F. ;
Mastrantonio, P. ;
Delmee, M. ;
Brazier, J. ;
Kuijper, E. ;
Poxton, I. .
CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (11) :1048-1057
[9]  
BARTLETT JG, 1978, LANCET, V1, P338
[10]   Clostridium difficile infection in Europe: a hospital-based survey [J].
Bauer, Martijn P. ;
Notermans, Daan W. ;
van Benthem, Birgit H. B. ;
Brazier, Jon S. ;
Wilcox, Mark H. ;
Rupnik, Maja ;
Monnet, Dominique L. ;
van Dissel, Jaap T. ;
Kuijper, Ed J. .
LANCET, 2011, 377 (9759) :63-73